Study comparing the safety and efficacy of tigecycline with ampicillin-sulbactam or amoxicillin-clavulanate to treat skin infections

Journal of Drugs in Dermatology, Jan, 2007

Sponsored by Wyeth. The purpose of this study is to compare the safety and efficacy of the antibiotic tigecycline with other antibiotics, ampicillin-sulbactam, and amoxicillin-clavutanate in the treatment of a complicated skin and/or skin structure infection.

Condition                 Intervention                  Phase

Skin Diseases, Bacterial  Drug: ampicillin-sulbactam    Phase III
                          Drug: amoxicillin-clavulante
                          Drug: vancomycin
                          Drug: teicoplanin
                          Drug: tigecycline

Study ID Numbers: 3074A1-900

ClinicalTrials.gov Identifier: NCT00368537

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2007 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale